Sivi-VG 2 Tablet ER
Marketer
Seema Pharmaceuticals
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Sivi-VG 2 Tablet ER
Diabetic patients can use the extended-release Sivi-VG 2 Tablet to manage their blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood sugar. Follow your physician's instructions precisely regarding dosage and duration; take it with food to prevent digestive discomfort. If you miss a dose, take it promptly, unless your next dose is imminent; in that case, omit the missed dose and resume your normal schedule. Never double the dose. Excessive intake can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic drugs, alcohol, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your doctor of any kidney, liver, or heart conditions before starting this medication. Pregnant or nursing mothers should seek medical advice before use. Your doctor will assess kidney function prior to treatment. Limit alcohol consumption as it may intensify side effects.
Primary Ingredients of Sivi-VG 2 Tablet ER
No text was provided. Please provide the text you want me to rephrase.
Uses of Sivi-VG 2 Tablet ER
Managing Type 2 Diabetes
Major Benefits of Sivi-VG 2 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Sivi-VG 2 Tablet ER with a meal.
Common Side effects of Sivi-VG 2 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Sivi-VG 2 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sivi-VG 2 Tablet ER with a meal.
How Sivi-VG 2 Tablet ER works:
Sivi-VG 2 ER tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct methods to achieve superior blood glucose management when single or dual drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, impeding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sivi-VG 2 Tablet ER and alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Sivi-VG 2 tablets might pose pregnancy risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Sivi-VG 2 tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Sivi-VG 2 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Close monitoring of renal function is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Sivi-VG 2 Tablet ER cautiously, potentially requiring dose modification. Consultation with a physician is advised. Sivi-VG 2 Tablet ER is contraindicated in individuals with severe liver disease.
What if you forget to take Sivi-VG 2 Tablet ER :
Should you forget a Sivi-VG 2 Tablet ER dose, take it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Sivi-VG 2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently